AAIC 2025 Abstract
Plasma biomarkers of neuroinflammation and neurodegeneration in relation to cerebral glucose hypometabolism in autosomal‐dominant Alzheimer's disease
By Catarina Tristão-Pereira, David Fernando Aguillón Niño, Ana Y. Baena, Show 14 more authorsYakeel T. Quiroz
Study in peopleMechanisms
Abstract
Background: Cerebral glucose hypometabolism, measured with ¹⁸ F‐fluorodeoxyglucose (FDG) PET, is a hallmark of Alzheimer's disease (AD). While FDG‐PET changes are highly effective at differentiating dementia types, the pathological bases for metabolic changes are complex.
